Supriya Lifescience Announces 18th AGM on Sept 24, 2026, Proposes Re. 1 Dividend
Supriya Lifescience will hold its 18th AGM on September 24, 2026, via VC/OAVM. The company proposes a final dividend of Re. 1 per share for FY26. The audited financials for FY26 and the Annual Report will be presented. Directors Dr. Saloni Satish Wagh and Ms. Shivani Satish Wagh are up for re-appointment.
The announcement pertains to a standard annual general meeting, dividend proposal, and financial reporting. These are routine corporate activities and are not expected to cause a significant immediate impact on the company's stock price or operations.
The announcement is a routine corporate event (AGM) with a dividend proposal and financial statement presentation. While the dividend is a positive factor, the overall nature of the announcement is procedural and does not contain significant new financial performance data or strategic shifts that would warrant a strongly positive sentiment.
Supriya Lifescience Limited has announced the 18th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 3:00 p.m. IST through Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The company will present the Audited Financial Statements for the financial year ended March 31, 2026.
During the AGM, a final dividend of Re. 1.00 per equity share (50%) for the financial year 2025-26 will be proposed for approval. The meeting will also address the re-appointment of directors, Dr. Saloni Satish Wagh and Ms. Shivani Satish Wagh, who are retiring by rotation.
Furthermore, the remuneration of Cost Auditors for FY 2026-27, amounting to ₹2,50,000 plus applicable taxes and out-of-pocket expenses payable to M/s. Rampurawala Mohammed A & Co., will be ratified. The Annual Report for FY 2025-26, including the Business Responsibility and Sustainability Report and the Notice of AGM, has been made available on the company's website and sent to shareholders via electronic mode.
The record date for determining entitlement to the final dividend, if approved, is fixed as Friday, September 4, 2026. The company has also provided detailed instructions for remote e-voting and participation in the AGM through VC/OAVM.
A plain-language summary of a public exchange filing by Supriya Lifescience Limited. Read the original for the full detail.